EcoDrugPlus

Ensembl ID : ENSOMEG00000012644
Gene Symbol: -
Cross references: -
347 Possible Orthologues:

Ensembl ID : ENSOMEG00000007026
Gene Symbol: S1PR1
1 Cross references
200 Possible Orthologues:

Ensembl ID : ENSOMEG00000013122
Gene Symbol: -
Cross references: -
168 Possible Orthologues:

Ensembl ID : ENSOMEG00000016502
Gene Symbol: -
Cross references: -
215 Possible Orthologues:

Ensembl ID : ENSOMEG00000017945
Gene Symbol: -
Cross references: -
197 Possible Orthologues:

Ensembl ID : ENSOMEG00000003576
Gene Symbol: -
Cross references: -
402 Possible Orthologues:

Ensembl ID : ENSOMEG00000020929
Gene Symbol: -
Cross references: -
183 Possible Orthologues:

Ensembl ID : ENSOMEG00000003403
Gene Symbol: -
1 Cross references
191 Possible Orthologues:

Ensembl ID : ENSOMEG00000020132
Gene Symbol: RPS4X
1 Cross references
494 Possible Orthologues:

Ensembl ID : ENSOMEG00000001355
Gene Symbol: -
Cross references: -
150 Possible Orthologues:

Ensembl ID : ENSOMEG00000001109
Gene Symbol: -
Cross references: -
197 Possible Orthologues:

Ensembl ID : ENSOMEG00000019956
Gene Symbol: RXRBB
1 Cross references
211 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).